Allogene retains control of cancer therapy after arbitration ruling
Go back to Allogene retains control of cancer therapy after arbitration ruling| (NASDAQ: ALLO) | Delayed: 2.08 -0.03 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.11 | 52 Week High | $ | |||
| Open | $2.13 | 52 Week Low | $ | |||
| Day High | $2.18 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $ | |||
| Volume | 9,136,320 | |||||
| (NASDAQ: CLLS) | Delayed: 3.30 +0.36 (12.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.94 | 52 Week High | $37.55 | |||
| Open | $3.31 | 52 Week Low | $16.35 | |||
| Day High | $3.39 | P/E | N/A | |||
| Day Low | $3.21 | EPS | $0.00 | |||
| Volume | 32,819 | |||||
